We compared the efficacy and complications of anticoagulation with warfarin in 258 patients with prosthetic heart valves treated with regimens of "moderate intensity" (prothrombin-time ratio, 1.5; international normalized ratio, 2.65) or "high intensity" (prothrombin-time ratio, 2.5; international normalized ratio, 9) in a prospective, randomized study. The two patient groups were followed up for 421 patient-years and 436 patient-years, respectively. Eleven patients were lost to follow-up. Thromboembolism occurred with similar frequency in the two groups (4.0 and 3.7 episodes per 100 patient-years, respectively), but there was a total of 6.2 bleeding episodes per 100 patient-years in the moderate-intensity group, as compared with 12.1 episodes in the high-intensity group (P less than 0.002). There were 5.2 episodes of minor bleeding per 100 patient-years in the moderate-intensity group, as compared with 10.1 episodes in the high-intensity group (P less than 0.01). Major bleeding was also more common in the high-intensity group (2.1 episodes per 100 patient-years--including the only two fatal hemorrhages--as compared with 0.95 episode in the moderate-intensity group), but the difference was not statistically significant. We conclude that a moderate anticoagulant effect (prothrombin-time ratio, about 1.5) in patients with a mechanical prosthetic heart valve offers protection equivalent to that of more intensive therapy, but at a significantly lower risk.
Source Information
Department of Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
This article has been cited by other articles:
Stassano, P., Di Tommaso, L., Monaco, M., Iorio, F., Pepino, P., Spampinato, N., Vosa, C.
(2009). Aortic valve replacement: a prospective randomized evaluation of mechanical versus biological valves in patients ages 55 to 70 years.. J Am Coll Cardiol
54: 1862-1868
[Abstract][Full Text]
Vahanian, A., Iung, B., Piérard, L., Dion, R., Pepper, J.
(2009). CHAPTER 21 Valvular Heart Disease. ESC Textbook of Cardiovascular Medicine
2: med-9780199566990-chapter-med-9780199566990-chapter
[Abstract][Full Text]
2006 WRITING COMMITTEE MEMBERS, , Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C. Jr, Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O'Gara, P. T., O'Rourke, R. A., Otto, C. M., Shah, P. M., Shanewise, J. S.
(2008). 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation
118: e523-e661
[Full Text]
Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C. Jr, Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O'Gara, P. T., O'Rourke, R. A., Otto, C. M., Shah, P. M., Shanewise, J. S., Nishimura, R. A., Carabello, B. A., Faxon, D. P., Freed, M. D., Lytle, B. W., O'Gara, P. T., O'Rourke, R. A., Shah, P. M.
(2008). 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol
52: e1-e142
[Full Text]
Thompson, J. L., Sundt, T. M., Sarano, M. E., Santrach, P. J., Schaff, H. V.
(2008). In-Patient International Normalized Ratio Self-Testing Instruction After Mechanical Heart Valve Implantation. Ann. Thorac. Surg.
85: 2046-2050
[Abstract][Full Text]
Ansell, J., Hirsh, J., Hylek, E., Jacobson, A., Crowther, M., Palareti, G.
(2008). Pharmacology and Management of the Vitamin K Antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest
133: 160S-198S
[Abstract][Full Text]
Schulman, S., Beyth, R. J., Kearon, C., Levine, M. N.
(2008). Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest
133: 257S-298S
[Abstract][Full Text]
Salem, D. N., O'Gara, P. T., Madias, C., Pauker, S. G.
(2008). Valvular and Structural Heart Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest
133: 593S-629S
[Abstract][Full Text]
Russo, A., Grigioni, F., Avierinos, J.-F., Freeman, W. K., Suri, R., Michelena, H., Brown, R., Sundt, T. M., Enriquez-Sarano, M.
(2008). Thromboembolic Complications After Surgical Correction of Mitral Regurgitation: Incidence, Predictors, and Clinical Implications. J Am Coll Cardiol
51: 1203-1211
[Abstract][Full Text]
Pengo, V., Palareti, G., Cucchini, U., Molinatti, M., Del Bono, R., Baudo, F., Ghirarduzzi, A., Pegoraro, C., Iliceto, S.
(2007). Low-Intensity Oral Anticoagulant Plus Low-Dose Aspirin During the First Six Months Versus Standard-Intensity Oral Anticoagulant Therapy After Mechanical Heart Valve Replacement: A Pilot Study of Low-Intensity Warfarin and Aspirin in Cardiac Prostheses (LIWACAP). CLIN APPL THROMB HEMOST
13: 241-248
[Abstract]
Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C. Jr, Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O'Gara, P. T., O'Rourke, R. A., Otto, C. M., Shah, P. M., Shanewise, J. S., Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Anderson, J. L., Antman, E. M., Faxon, D. P., Fuster, V., Halperin, J. L., Hiratzka, L. F., Hunt, S. A., Lytle, B. W., Nishimura, R., Page, R. L., Riegel, B.
(2006). ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol
48: e1-e148
[Full Text]
Kulik, A., Rubens, F. D., Wells, P. S., Kearon, C., Mesana, T. G., van Berkom, J., Lam, B.-K.
(2006). Early Postoperative Anticoagulation After Mechanical Valve Replacement: A Systematic Review. Ann. Thorac. Surg.
81: 770-781
[Abstract][Full Text]
Min, K. A., Zhu, X., Oh, J. M., Shin, W. G.
(2006). Effect of oxolamine on anticoagulant effect of warfarin. Am J Health Syst Pharm
63: 153-156
[Full Text]
Butchart, E. G., Gohlke-Barwolf, C., Antunes, M. J., Tornos, P., De Caterina, R., Cormier, B., Prendergast, B., Iung, B., Bjornstad, H., Leport, C., Hall, R. J.C., Vahanian, A., on behalf of the Working Groups on Valvular Heart,
(2005). Recommendations for the management of patients after heart valve surgery. Eur Heart J
26: 2463-2471
[Abstract][Full Text]
Stefanidis, C., Nana, A. M., De Canniere, D., Antoine, M., Jansens, J.-L., Huynh, C.-H., Le Clerc, J.-L.
(2005). 10-Year Experience With the ATS Mechanical Valve in the Mitral Position. Ann. Thorac. Surg.
79: 1934-1938
[Abstract][Full Text]
Schulman, S., Beyth, R. J.
(2005). Risk of bleeding with long-term antithrombotic therapy in atrial fibrillation. Eur Heart J Suppl
7: C34-C40
[Abstract][Full Text]
Hering, D., Piper, C., Bergemann, R., Hillenbach, C., Dahm, M., Huth, C., Horstkotte, D.
(2005). Thromboembolic and Bleeding Complications Following St. Jude Medical Valve Replacement: Results of the German Experience With Low-Intensity Anticoagulation Study. Chest
127: 53-59
[Abstract][Full Text]
Smythe, M. A., Dager, W. E., Patel, N. M.
(2004). Managing Complications of Anticoagulant Therapy. Journal of Pharmacy Practice
17: 327-346
[Abstract]
Butchart, E. G., Gohlke-Barwolf, C.
(2004). Anticoagulation management of patients with prosthetic valves. J Am Coll Cardiol
44: 1143-1144
[Full Text]
Vink, R., Kraaijenhagen, R. A., Levi, M.
(2004). Reply. J Am Coll Cardiol
44: 1144-1145
[Full Text]
Ansell, J., Hirsh, J., Poller, L., Bussey, H., Jacobson, A., Hylek, E.
(2004). The Pharmacology and Management of the Vitamin K Antagonists: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest
126: 204S-233S
[Abstract][Full Text]
Levine, M. N., Raskob, G., Beyth, R. J., Kearon, C., Schulman, S.
(2004). Hemorrhagic Complications of Anticoagulant Treatment: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest
126: 287S-310S
[Abstract][Full Text]
Salem, D. N., Stein, P. D., Al-Ahmad, A., Bussey, H. I., Horstkotte, D., Miller, N., Pauker, S. G.
(2004). Antithrombotic Therapy in Valvular Heart Disease--Native and Prosthetic: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest
126: 457S-482S
[Abstract][Full Text]
O'Donnell, M., Hirsh, J.
(2004). Establishing an Optimal Therapeutic Range for Coumarins: Filling in the Gaps. Arch Intern Med
164: 588-590
[Full Text]
Torn, M., van der Meer, F. J. M., Rosendaal, F. R.
(2004). Lowering the Intensity of Oral Anticoagulant Therapy: Effects on the Risk of Hemorrhage and Thromboembolism. Arch Intern Med
164: 668-673
[Abstract][Full Text]
Paul, N., Kosinski, C. M., Gelber, A. C., Saleh, A. S., Stern, S. D., Crowther, M., Ginsberg, J.
(2003). Warfarin Prophylaxis in the Antiphospholipid Antibody Syndrome. NEJM
349: 2568-2570
[Full Text]
Man-Son-Hing, M., Laupacis, A.
(2003). Anticoagulant-Related Bleeding in Older Persons With Atrial Fibrillation: Physicians' Fears Often Unfounded. Arch Intern Med
163: 1580-1586
[Abstract][Full Text]
Hirsh, J., Fuster, V., Ansell, J., Halperin, J. L.
(2003). American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. J Am Coll Cardiol
41: 1633-1652
[Full Text]
Hirsh, J., Fuster, V., Ansell, J., Halperin, J. L.
(2003). American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy. Circulation
107: 1692-1711
[Full Text]
Pegoraro, C., Biasiolo, A., Iliceto, S., Pengo, V.
(2003). Mechanical Prosthetic Heart Valve Thrombosis Despite Optimal Anticoagulation in a Patient with Congenital Thrombophilia (Factor V Leiden). CLIN APPL THROMB HEMOST
9: 89-90
[Abstract]
Tang, E. O. Y., Lai, C. S., Lee, K. K., Wong, R. S., Cheng, G., Chan, T. Y.
(2003). Relationship Between Patients' Warfarin Knowledge and Anticoagulation Control. The Annals of Pharmacotherapy
37: 34-39
[Abstract][Full Text]
Oden, A., Fahlen, M.
(2002). Oral anticoagulation and risk of death: a medical record linkage study. BMJ
325: 1073-1075
[Abstract][Full Text]
Lim, K. H. H., Caputo, M., Ascione, R., Wild, J., West, R., Angelini, G. D., Bryan, A. J., Calafiore, S. A. M.
(2002). Prospective randomized comparison of CarboMedics and St Jude Medical bileaflet mechanical heart valve prostheses: An interim report. J. Thorac. Cardiovasc. Surg.
123: 21-32
[Abstract][Full Text]
Schror, K.
(2001). Combination of oral anticoagulant and platelet inhibitor drugs: focus on the pharmacological aspects of optimizing antithrombotic therapy in mechanical heart valve replacement. Eur Heart J Suppl
3: Q54-Q59
[Abstract]
Al-Saady, N.M., Sopher, M.
(2001). Prothrombotic markers in atrial fibrillation: what is new?. Eur Heart J
22: 1635-1639
Ananthasubramaniam, K., Beattie, J. N., Rosman, H. S., Jayam, V., Borzak, S.
(2001). How Safely and for How Long Can Warfarin Therapy Be Withheld in Prosthetic Heart Valve Patients Hospitalized With a Major Hemorrhage?. Chest
119: 478-484
[Abstract][Full Text]
Hirsh, J., Dalen, J. E., Anderson, D. R., Poller, L., Bussey, H., Ansell, J., Deykin, D.
(2001). Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range. Chest
119
: 8S-21S
[Full Text]
Ansell, J., Hirsh, J., Dalen, J., Bussey, H., Anderson, D., Poller, L., Jacobson, A., Deykin, D., Matchar, D.
(2001). Managing Oral Anticoagulant Therapy. Chest
119
: 22S-38S
[Full Text]
Levine, M. N., Raskob, G., Landefeld, S., Kearon, C.
(2001). Hemorrhagic Complications of Anticoagulant Treatment. Chest
119
: 108S-121S
[Full Text]
Stein, P. D., Alpert, J. S., Bussey, H. I., Dalen, J. E., Turpie, A. G.G.
(2001). Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves. Chest
119
: 220S-227S
[Full Text]
Beyth, R. J., Quinn, L., Landefeld, C. S.
(2000). A Multicomponent Intervention To Prevent Major Bleeding Complications in Older Patients Receiving Warfarin: A Randomized, Controlled Trial. ANN INTERN MED
133: 687-695
[Abstract][Full Text]
Hammermeister, K., Sethi, G. K., Henderson, W. G., Grover, F. L., Oprian, C., Rahimtoola, S. H.
(2000). Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial. J Am Coll Cardiol
36: 1152-1158
[Abstract][Full Text]
Couris, R. R., Tataronis, G. R., Dallal, G. E., Blumberg, J. B., Dwyer, J. T.
(2000). Assessment of Healthcare Professionals' Knowledge About Warfarin-Vitamin K Drug-Nutrient Interactions. J. Am. Coll. Nutr.
19: 439-445
[Abstract][Full Text]
Kvidal, P, Bergstrom, R, Malm, T, Stahle, E
(2000). Long-term follow-up of morbidity and mortality after aortic valve replacement with a mechanical valve prosthesis. Eur Heart J
21: 1099-1111
[Abstract]
Ansell, J. E., Weitz, J. I., Comerota, A. J.
(2000). Advances in Therapy and the Management of Antithrombotic Drugs for Venous Thromboembolism. ASH Education Book
2000: 266-284
[Abstract][Full Text]
Al-Saady, N M, Obel, O A, Camm, A J
(1999). Left atrial appendage: structure, function, and role in thromboembolism. Heart
82: 547-554
[Abstract][Full Text]
Guglielmi, C., Toscano, G., Pistorio, V., Vendramin, I., Bottio, T., Thiene, G., Casarotto, D.
(1999). Reoperations for acute prosthetic thrombosis and pannus: an assessment of rates, relationship and risk. Eur. J. Cardiothorac. Surg.
16: 74-80
[Abstract][Full Text]
Jamieson, W.R. E., Miyagishima, R. T., Grunkemeier, G. L., Germann, E., Henderson, C., Fradet, G. J., Burr, L. H., Lichtenstein, S. V.
(1999). Bileaflet mechanical prostheses performance in mitral position. Eur. J. Cardiothorac. Surg.
15: 786-794
[Abstract][Full Text]
Sawicki, P. T., for the Working Group for the Study of Patient Sel,
(1999). A Structured Teaching and Self-management Program for Patients Receiving Oral Anticoagulation: A Randomized Controlled Trial. JAMA
281: 145-150
[Abstract][Full Text]
Altman, R.
(1998). Controversies in Antithrombotic Therapy in Cardiovascular Diseases. CLIN APPL THROMB HEMOST
4: 11-24
[Abstract]
Baker, W. F. JR
(1998). Thrombosis and Hemostasis in Cardiology: Review of Pathophysiology and Clinical Practice (Part I). CLIN APPL THROMB HEMOST
4: 51-75
[Abstract]
Ninet, J., Tronc, F., Robin, J., Curtil, A., Aleksic, I., Champsaur, G.
(1998). Mechanical versus biological isolated aortic valvular replacement after the age of 70: equivalent long-term results. Eur. J. Cardiothorac. Surg.
13: 84-89
[Abstract][Full Text]
Acar, J., Iung, B., Boissel, J. P., Samama, M. M., Michel, P. L., Teppe, J. P., Pony, J. C., Le Breton, H., Thomas, D., Isnard, R., de Gevigney, G., Viguier, E., Sfihi, A., Hanania, G., Ghannem, M., Mirode, A., Nemoz, C.
(1996). AREVA: Multicenter Randomized Comparison of Low-Dose Versus Standard-Dose Anticoagulation in Patients With Mechanical Prosthetic Heart Valves. Circulation
94: 2107-2112
[Abstract][Full Text]
Vongpatanasin, W., Hillis, L. D., Lange, R. A.
(1996). Prosthetic Heart Valves. NEJM
335: 407-416
[Full Text]
Nistal, J. F., Hurle, A., Revuelta, J. M., Gandarillas, M.
(1996). CLINICAL EXPERIENCE WITH THE CARBOMEDICS VALVE: EARLY RESULTS WITH A NEW BILEAFLET MECHANICAL PROSTHESIS. J. Thorac. Cardiovasc. Surg.
112: 59-68
[Abstract][Full Text]
Hirsh, J., Hoak, J.
(1996). Management of Deep Vein Thrombosis and Pulmonary Embolism : A Statement for Healthcare Professionals From the Council on Thrombosis (in Consultation With the Council on Cardiovascular Radiology), American Heart Association. Circulation
93: 2212-2245
[Full Text]
The Stroke Prevention in Atrial Fibrillation Inves,
(1996). Bleeding During Antithrombotic Therapy in Patients With Atrial Fibrillation. Arch Intern Med
156: 409-416
[Abstract]
Blackshear, J. L., Odell, J. A.
(1996). Appendage Obliteration to Reduce Stroke in Cardiac Surgical Patients With Atrial Fibrillation. Ann. Thorac. Surg.
61: 755-759
[Abstract][Full Text]
Amiral, J.
(1995). State-of-the-Art Review: Usefulness of Laboratory Techniques for Evaluating Antithrombotic Efficacy of New Therapeutic Strategies. CLIN APPL THROMB HEMOST
1: 243-259
[Abstract]
Hart, R. G., Boop, B. S., Anderson, D. C.
(1995). Oral Anticoagulants and Intracranial Hemorrhage : Facts and Hypotheses. Stroke
26: 1471-1477
[Abstract][Full Text]
Cannegieter, S.C., Rosendaal, F.R., Wintzen, A.R., van der Meer, F.J.M., Vandenbroucke, J.P., Briet, E.
(1995). Optimal Oral Anticoagulant Therapy in Patients with Mechanical Heart Valves. NEJM
333: 11-17
[Abstract][Full Text]
Fihn, S. D.
(1995). Aiming for Safe Anticoagulation. NEJM
333: 54-55
[Full Text]
Brękken, S. K., Russell, D., Brucher, R., Svennevig, J.
(1995). Incidence and Frequency of Cerebral Embolic Signals in Patients With a Similar Bileaflet Mechanical Heart Valve. Stroke
26: 1225-1230
[Abstract][Full Text]
Khamashta, M. A., Cuadrado, M. J., Mujic, F., Taub, N. A., Hunt, B. J., Hughes, G. R.V.
(1995). The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome. NEJM
332: 993-997
[Abstract][Full Text]
Sturzenegger, M., Beer, J. H., Rihs, F.
(1995). Monitoring Combined Antithrombotic Treatments in Patients With Prosthetic Heart Valves Using Transcranial Doppler and Coagulation Markers. Stroke
26: 63-69
[Abstract][Full Text]
Gottlieb, L. K., Salem-Schatz, S.
(1994). Anticoagulation in Atrial Fibrillation: Does Efficacy in Clinical Trials Translate Into Effectiveness in Practice?. Arch Intern Med
154: 1945-1953
[Abstract]
Horstkotte, D., Schulte, H. D., Bircks, W., Strauer, B. E.
(1994). Lower intensity anticoagulation therapy results in lower complication rates with the St. Jude Medical prosthesis. J. Thorac. Cardiovasc. Surg.
107: 1136-1145
[Abstract][Full Text]
Cannegieter, S.C., van der Meer, F.J.M., Briet, E., Rosendaal, F.R., Bussey, H. I., Linn, W. D., Keimowitz, R. M., Fitzgerald, D. J., Turpie, A.G.G., Gent, M., Laupacis, A., Hirsh, J.
(1994). Warfarin and Aspirin after Heart-Valve Replacement. NEJM
330: 507-509
[Full Text]
Eckman, M. H., Levine, H. J., Pauker, S. G.
(1993). Effect of Laboratory Variation in the Prothrombin-Time Ratio on the Results of Oral Anticoagulant Therapy. NEJM
329: 696-702
[Abstract][Full Text]
Turpie, A., Gent, M., Laupacis, A., Latour, Y., Gunstensen, J., Basile, F., Klimek, M., Hirsh, J.
(1993). A Comparison of Aspirin with Placebo in Patients Treated with Warfarin after Heart-Valve Replacement. NEJM
329: 524-529
[Abstract][Full Text]
van der Meer, F. J. M., Rosendaal, F. R., Vandenbroucke, J. P., Briet, E.
(1993). Bleeding Complications in Oral Anticoagulant Therapy: An Analysis of Risk Factors. Arch Intern Med
153: 1557-1562
[Abstract]
Anderson, D. R., Harrison, L., Hirsh, J.
(1993). Evaluation of a Portable Prothrombin Time Monitor for Home Use by Patients Who Require Long-term Oral Anticoagulant Therapy. Arch Intern Med
153: 1441-1447
[Abstract]
Hammermeister, K. E., Sethi, G. K., Henderson, W. G., Oprian, C., Kim, T., Rahimtoola, S., The Veterans Affairs Cooperative Study on Valvular,
(1993). A Comparison of Outcomes in Men 11 Years after Heart-Valve Replacement with a Mechanical Valve or Bioprosthesis. NEJM
328: 1289-1296
[Abstract][Full Text]
Landefeld, C. S., Anderson, P. A.
(1992). Guideline-based Consultation To Prevent Anticoagulant-related Bleeding: A Randomized, Controlled Trial in a Teaching Hospital. ANN INTERN MED
116: 829-837
[Abstract]
Kutner, M., Nixon, G., Silverstone, F.
(1991). Physicians' Attitudes Toward Oral Anticoagulants and Antiplatelet Agents for Stroke Prevention in Elderly Patients With Atrial Fibrillation. Arch Intern Med
151: 1950-1953
[Abstract]
(1990). ANTICOAGULATION IN PATIENTS WITH PROSTHETIC VALVES: LESS IS MORE. JWatch General
1990: 2-2
[Full Text]
Clagett, G. P.
(1990). Antithrombotic Drugs and Vascular Surgery. PERSPECT VASC SURG ENDOVASC THER
3: 79-102
Previous
